Muhammad Absar, Nawaf Alanazi, Abdulaziz Siyal, Masood Shammas, Amer Mahmood, Sulman Basit, Sarah AlMukhaylid, and Zafar Iqbal. “CLINICAL VALIDATION OF ANKRD36 MUTATIONS AS A NOVEL BIOMARKER FOR MONITORING EARLY PROGRESSION AND TIMELY CLINICAL INTERVENTIONS IN BLAST CRISIS CML”. Journal of Population Therapeutics and Clinical Pharmacology 29, no. 02 (February 23, 2022): 311–320. Accessed July 16, 2024. https://jptcp.com/index.php/jptcp/article/view/4161.